Expensive HL7 Interfaces not Required November 3, 2016 - Paramus, NJ - Advanced Data Systems (ADS) is pleased to announce its EMRdirect has been successfully implemented for sending finalized reports directly to any referring physician’s EMR without requiring expensive HL7 interfaces.
PARAMUS, N.J., May 6, 2016 (Yahoo Finance) -- Partnership will enable practices to better coordinate care for patients with chronic diseases and meet Medicare reimbursement requirements.
March 21, 2016 – Paramus, NJ - Advanced Data Systems Corp. (ADS) announces their new EMRdirect application, which delivers finalized reports through ADS’ MedicsRIS to any referring physician’s EMR without an HL7 interface, has been successfully tested. ADS will be rolling out EMRdirect to select MedicsRIS installations for further beta testing in April and May with general release scheduled by June 2016.
November 23, 2015 – Paramus, NJ - Advanced Data Systems (ADS), a leading provider of RIS automation, is pleased to announce its connection with Surescripts for the delivery of finalized reports between imaging centers and their referring physicians’ EHRs. This new product – EMRdirect – will be part of MedicsRIS and will utilize the Surescripts network as the digital report delivery system. Surescripts is the nation’s most comprehensive health information network.
Clients Maintain Excellent Rate on First Attempt Clearinghouse Claims October 22, 2015 - Paramus NJ -- Advanced Data Systems Corp. (ADS) is pleased to announce that with almost one million ICD-10 claims submitted by its clients since October 1, their 99% success rate on first attempt clearinghouse claims prior to ICD-10 essentially remains constant, post-ICD-10.
PARAMUS, N.J., May 27, 2015 (PRNewswire) -- Advanced Data Systems Corp. (ADS) is pleased to announce that its MedicsDocAssistant™ EHR and MedicsPremier™ PM are being successfully utilized by both medical practices (sites) as well as sponsors and clinical research organizations (CROs) to track clinical trial outcomes, to report on clinical trial data as required, and to identify patient candidates and sites for clinical trials.